| Literature DB >> 26010585 |
Girish Chandra1,2, Yang Won Moon3, Yoonji Lee3, Ji Yong Jang3, Jayoung Song1, Akshata Nayak1, Kawon Oh1,3, Varughese A Mulamoottil3, Pramod K Sahu1, Gyudong Kim1, Tong-Shin Chang3, Minsoo Noh1, Sang Kook Lee1, Sun Choi3, Lak Shin Jeong1.
Abstract
On the basis of the potent inhibitory activity of neplanocin A (1) against S-adenosylhomocysteine (AdoHcy) hydrolase, we analyzed the comprehensive structure-activity relationships by modifying the adenine and carbasugar moiety of 1 to find the pharmacophore in the active site of the enzyme. The introduction of 7-deazaadenine instead of adenine eliminated the inhibitory activity against the AdoHcy hydrolase, while 3-deazaadenine maintained the inhibitory activity of the enzyme, indicating that N-7 is essential for its role as a hydrogen bonding acceptor. The substitution of hydrogen at the 6'-position with fluorine increased the inhibitory activity of the enzyme. The one-carbon homologation at the 5'-position generally decreased the inhibitory activity of the enzyme, indicating that steric repulsion exists. A molecular docking study also supported these experimental data. In this study, 6'-fluoroneplanocin A (2) was the most potent inhibitor of AdoHcy hydrolase (IC50 = 0.24 μM). It showed a potent anti-VSV activity (EC50 = 0.43 μM) and potent anticancer activity in all the human tumor cell lines tested.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26010585 DOI: 10.1021/acs.jmedchem.5b00553
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446